|Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas|
JL Teeling, RR French, MS Cragg, J van den Brakel, M Pluyter, H Huang, ...
Blood 104 (6), 1793-1800, 2004
|The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20|
JL Teeling, WJM Mackus, LJJM Wiegman, JHN van den Brakel, SA Beers, ...
The Journal of Immunology 177 (1), 362-371, 2006
|Low-grade inflammation, diet composition and health: current research evidence and its translation|
AM Minihane, S Vinoy, WR Russell, A Baka, HM Roche, KM Tuohy, ...
British Journal of Nutrition 114 (7), 999-1012, 2015
|Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration|
VH Perry, J Teeling
Seminars in immunopathology 35 (5), 601-612, 2013
|The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I: C)|
C Cunningham, S Campion, J Teeling, L Felton, VH Perry
Brain, behavior, and immunity 21 (4), 490-502, 2007
|CD20-induced lymphoma cell death is independent of both caspases and its redistribution into triton X-100 insoluble membrane rafts|
HTC Chan, D Hughes, RR French, AL Tutt, CA Walshe, JL Teeling, ...
Cancer research 63 (17), 5480-5489, 2003
|Systemic infection and inflammation in acute CNS injury and chronic neurodegeneration: underlying mechanisms|
JL Teeling, VH Perry
Neuroscience 158 (3), 1062-1073, 2009
|Periodontitis and cognitive decline in Alzheimer’s disease|
M Ide, M Harris, A Stevens, R Sussams, V Hopkins, D Culliford, J Fuller, ...
PloS one 11 (3), e0151081, 2016
|Therapeutic efficacy of intravenous immunoglobulin preparations depends on the immunoglobulin G dimers: studies in experimental immune thrombocytopenia|
JL Teeling, T Jansen-Hendriks, TW Kuijpers, M de Haas, ...
Blood, The Journal of the American Society of Hematology 98 (4), 1095-1099, 2001
|Age related changes in microglial phenotype vary between CNS regions: grey versus white matter differences|
AD Hart, A Wyttenbach, VH Perry, JL Teeling
Brain, behavior, and immunity 26 (5), 754-765, 2012
|Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial|
J Butchart, L Brook, V Hopkins, J Teeling, U Püntener, D Culliford, ...
Neurology 84 (21), 2161-2168, 2015
|Developing novel blood-based biomarkers for Alzheimer's disease|
HM Snyder, MC Carrillo, F Grodstein, K Henriksen, A Jeromin, ...
Alzheimer's & Dementia 10 (1), 109-114, 2014
|IL-8 as antibody therapeutic target in inflammatory diseases: reduction of clinical activity in palmoplantar pustulosis|
L Skov, FJ Beurskens, COC Zachariae, S Reitamo, J Teeling, D Satijn, ...
The Journal of Immunology 181 (1), 669-679, 2008
|Sub-pyrogenic systemic inflammation impacts on brain and behavior, independent of cytokines|
JL Teeling, LM Felton, RMJ Deacon, C Cunningham, JNP Rawlins, ...
Brain, behavior, and immunity 21 (6), 836-850, 2007
|The effect of non-steroidal anti-inflammatory agents on behavioural changes and cytokine production following systemic inflammation: Implications for a role of COX-1|
JL Teeling, C Cunningham, TA Newman, VH Perry
Brain, behavior, and immunity 24 (3), 409-419, 2010
|Long-term impact of systemic bacterial infection on the cerebral vasculature and microglia|
U Püntener, SG Booth, VH Perry, JL Teeling
Journal of neuroinflammation 9 (1), 1-13, 2012
|Systemic inflammation modulates Fc receptor expression on microglia during chronic neurodegeneration|
K Lunnon, JL Teeling, AL Tutt, MS Cragg, MJ Glennie, VH Perry
The Journal of Immunology 186 (12), 7215-7224, 2011
|CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses|
FVV Castro, AL Tutt, AL White, JL Teeling, S James, RR French, ...
European journal of immunology 38 (8), 2263-2273, 2008
|Accelerated autoantibody clearance by intravenous immunoglobulin therapy: studies in experimental models to determine the magnitude and time course of the effect|
WK Bleeker, JL Teeling, CE Hack
Blood, The Journal of the American Society of Hematology 98 (10), 3136-3142, 2001
|Targeting innate immunity for neurodegenerative disorders of the central nervous system|
KI Andreasson, AD Bachstetter, M Colonna, F Ginhoux, C Holmes, ...
Journal of neurochemistry 138 (5), 653-693, 2016